Efficacy Preclinical Studies Conducted by UTRF, UTHSC, and Veru Inc.’s University-Industry Partnership Memphis, Tennessee: A research collaboration between the University of Tennessee Health Science Center (UTHSC), the University of Tennessee Research Foundation (UTRF), and biopharmaceutical company Veru Inc. has resulted in a promising next generation oral cancer therapy, VERU-111, which has the potential to treat (read more)
UTHSC
Following the Molecules: From Drug Discovery to Entrepreneurship
A new startup born at the University of Tennessee Health Science Center (UTHSC) in Memphis aims to reshape treatment for pediatric leukemia and neuroblastoma. SEAK Therapeutics, LLC, began in the research lab of Pharmaceutical Sciences Professor Wei Li, who also serves as the Director of the UT College of Pharmacy Drug Discovery Center. In 2017, (read more)
UTRF Inventor Spotlight: Dr. Rajashekhar Gangaraju
New Vision for Treating the Effects of Diabetes Diabetes is among the most prevalent diseases in the world. Though chronic sufferers experience a wide range of complications, one of the most devastating conditions is diabetic retinopathy – a leading cause of blindness in adults across the United States. The University of Tennessee Health Science Center’s (read more)